Stockman Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$21.3M Sell
177,107
-558
-0.3% -$64.4K 2.35% 14
2025
Q4
$18.7M Sell
177,665
-310
-0.2% -$29.1K 2.18% 15
2025
Q3
$14.9M Buy
177,975
+9,111
+5% +$750K 1.85% 17
2025
Q2
$13.4M Buy
168,864
+17,799
+12% +$1.41M 1.82% 15
2025
Q1
$13.6M Buy
151,065
+23,053
+18% +$2.15M 2.01% 14
2024
Q4
$12.7M Buy
128,012
+12,091
+10% +$1.25M 1.99% 14
2024
Q3
$13.2M Buy
115,921
+6,375
+6% +$757K 2.05% 14
2024
Q2
$13.6M Buy
109,546
+502
+0.5% +$64.7K 2.38% 11
2024
Q1
$14.4M Sell
109,044
-1,943
-2% -$239K 2.54% 9
2023
Q4
$12.1M Buy
110,987
+2,651
+2% +$275K 2.41% 10
2023
Q3
$11.2M Sell
108,336
-894
-0.8% -$96.4K 2.46% 10
2023
Q2
$12.6M Sell
109,230
-587
-0.5% -$66.6K 2.71% 7
2023
Q1
$11.7M Sell
109,817
-4,332
-4% -$468K 2.61% 6
2022
Q4
$12.7M Sell
114,149
-7,288
-6% -$745K 2.91% 4
2022
Q3
$10.5M Buy
121,437
+6,637
+6% +$592K 2.83% 4
2022
Q2
$10.5M Buy
114,800
+15,325
+15% +$1.36M 2.67% 6
2022
Q1
$8.16M Sell
99,475
-944
-0.9% -$74.4K 1.69% 17
2021
Q4
$7.7M Buy
100,419
+1,672
+2% +$133K 1.57% 18
2021
Q3
$7.42M Buy
98,747
+6,245
+7% +$475K 1.65% 15
2021
Q2
$7.19M Buy
92,502
+3,072
+3% +$228K 1.72% 14
2021
Q1
$6.58M Buy
89,430
+10,140
+13% +$748K 1.83% 14
2020
Q4
$6.19M Sell
79,290
-9,582
-11% -$733K 1.9% 12
2020
Q3
$7.03M Sell
88,872
-19
-0% -$1.49K 2.56% 6
2020
Q2
$6.56M Buy
88,891
+2,826
+3% +$213K 2.46% 5
2020
Q1
$6.32M Buy
86,065
+1,078
+1% +$84.7K 2.8% 4
2019
Q4
$7.38M Sell
84,987
-1,950
-2% -$160K 2.62% 5
2019
Q3
$6.98M Buy
86,937
+14
+0% +$1.12K 2.68% 6
2019
Q2
$6.96M Sell
86,923
-1,476
-2% -$113K 2.84% 4
2019
Q1
$7.01M Sell
88,399
-12,866
-13% -$962K 3.07% 2
2018
Q4
$7.38M Sell
101,265
-667
-0.7% -$47.1K 3.53% 1
2018
Q3
$6.9M Sell
101,932
-4,646
-4% -$296K 2.97% 2
2018
Q2
$6.17M Sell
106,578
-4,977
-4% -$281K 2.82% 3
2018
Q1
$5.8M Buy
111,555
+76,129
+215% +$4.11M 2.65% 4
2017
Q4
$1.9M Buy
35,426
+10,559
+42% +$585K 0.85% 45
2017
Q3
$1.52M Buy
24,867
+3,938
+19% +$239K 0.73% 44
2017
Q2
$1.28M Sell
20,929
-4,579
-18% -$279K 1.28% 26
2017
Q1
$1.55M Buy
25,508
+1,564
+7% +$94.9K 0.88% 42
2016
Q4
$1.34M Sell
23,944
-3,479
-13% -$204K 0.82% 46
2016
Q3
$1.63M Buy
27,423
+4,234
+18% +$248K 1.01% 45
2016
Q2
$1.27M Buy
23,189
+262
+1% +$13.9K 1% 41
2016
Q1
$1.16M Sell
22,927
-492
-2% -$24.1K 0.92% 45
2015
Q4
$1.18M Sell
23,419
-1,435
-6% -$72.3K 0.95% 43
2015
Q3
$1.17M Buy
24,854
+1,450
+6% +$77K 1.01% 45
2015
Q2
$1.27M Buy
23,404
+219
+0.9% +$12.3K 1.08% 44
2015
Q1
$1.27M Sell
23,185
-288
-1% -$16.3K 1.09% 43
2014
Q4
$1.27M Buy
+23,473
New +$1.31M 1.09% 44

Other funds holding MRK

Stockman Wealth Management's MRK Position: Q1 2026 in Review

Stockman Wealth Management reduced its Merck (MRK) stake by 0.31% in Q1 2026, selling an estimated $64.4K and leaving 177,107 shares worth $21.3M. The position accounts for 2.35% of the portfolio, ranked #14.

Stockman Wealth Management first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Stockman Wealth Management held 177,107 shares of Merck worth $21.3M as of Q1 2026.
  • Stockman Wealth Management sold 558 Merck shares in Q1 2026, an estimated $64.4K.
  • Merck made up 2.35% of Stockman Wealth Management's portfolio in Q1 2026, its #14 holding.
  • Stockman Wealth Management first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Stockman Wealth Management's 13F filing for Q1 2026, filed 13 Apr 2026.